References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30. 10.3322/caac.21332
- Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-86. 10.1056/NEJM197111182852108
- Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998; 55: 575-81.
- Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-39.
- Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307-8. 10.1016/S0140-6736(02)09520-X
- Devries AF, Griebel J, Kremser C, Judmaier W, Gneiting T, Kreczy A, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 2001; 61: 2513-6.
- DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56: 958-65.
- Foti PV, Privitera G, Piana S, Palmucci S, Spatola C, Bevilacqua R, et al. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy. Eur J Radiol Open 2016; 3: 145-52. 10.1016/j.ejro.2016.06.003
- Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-35. 10.2214/AJR.06.1403
- Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-25.
- Ha HI, Kim AY, Yu CS, Park SH, Ha HK. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol 2013; 23: 3345-53. 10.1007/s00330-013-2936-5
- van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013; 269: 101-12. 10.1148/radiol.13122833
- Avallone A, Delrio P, Guida C, Tatangelo F, Petrillo A, Marone P, et al. Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. Brit J Cancer 2006; 94: 1809-15. 10.1038/sj.bjc.6603195
- Avallone A, Delrio P, Pecori B, Tatangelo F, Petrillo A, Scott N, et al. Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome. Int J Radiat Oncol 2011; 79: 670-6. 10.1016/j.ijrobp.2009.12.007
- van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-82. 10.1016/S1470-2045(11)70097-3
- Vermaas M, Ferenschild FT, Nuyttens JJ, Marinelli AW, Wiggers T, van der Sijp JR, et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 2005; 48: 918-28. 10.1007/s10350-004-0891-6
- Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-5. 10.1200/JCO.2006.06.7629
- Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23. 10.1056/NEJMoa060829
- Sathyakumar K, Chandramohan A, Masih D, Jesudasan MR, Pulimood A, Eapen A. Best MRI predictors of complete response to neoadjuvant chemo-radiation in locally advanced rectal cancer. Br J Radiol 2016; 89: 20150328. 10.1259/bjr.20150328
- Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10: 145-7. 10.1038/nm988
- Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 2007; 33: 452-8. 10.1016/j.ejso.2006.09.021
- Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002; 168: 42-8. 10.1080/110241502317307562
- Luna-Perez P, Delgado S, Labastida S, Ortiz N, Rodriguez D, Herrera L. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma. Ann Surg Oncol 1996; 3: 526-33.
- Delrio P, Avallone A, Guida C, Lastoria S, Tatangelo F, Cascini GM, et al. Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trial. Suppl Tumori 2005; 4: S8.
- Delrio P, Lastoria S, Avallone A, Ravo V, Guida C, Cremona F, et al. Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum. Tumori 2003; 89(4 Suppl): 50-3.
- Petrillo A, Catalano O, Delrio P, Avallone A, Guida C, Filice S, et al. Post-treatment fistulas in patients with rectal cancer: MRI with rectal superparamagnetic contrast agent. Abdom Imaging 2007; 32: 328-31. 10.1007/s00261-006-9028-9
- Pecori B, Lastoria S, Caracò C, Celentani M, Tatangelo F, Avallone A, et al. Sequential PET/CT with [18F]-FDG predicts pathological tumor response to preoperative short course radiotherapy with delayed Surgery in patients with locally advanced rectal cancer using logistic regression analysis. PLoS One 2017; 12: e0169462. 10.1371/journal.pone.0169462
- Sansone M, Fusco R, Petrillo A, Petrillo M, Bracale M. An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging. Med Biol Eng Comput 2011; 49: 485-95. 10.1007/s11517-010-0695-x
- Fusco R, Sansone M, Petrillo M, Antonella Petrillo. Influence of parameterization on tracer kinetic modeling in DCE-MRI. J Med Biol Eng 2012; 34: 157-63. 10.5405/jmbe.1097
- Fusco R, Sansone M, Maffei S, Petrillo A. Dynamic contrast-enhanced MRI in breast cancer: a comparison between distributed and compartmental tracer kinetic models. J Biomed Graph Comput 2012; 2: 23. 10.5430/jbgc.v2n2p23
- Gunderson LL, Sargent DJ, Tepper JE, O’Connell MJ, Allmer C, Smalley SR, et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol 2002; 54: 386-96.
- Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Connell MJ, Begovic M, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 2004; 22: 1785-96. 10.1200/JCO.2004.08.173
- Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 2007; 8: 245-55. 10.1016/S1470-2045(07)70075-X
- Kremser C, Trieb T, Rudisch A, Judmaier W, de Vries A. Dynamic t(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging 2007; 26: 662-71. 10.1002/jmri.21034
- Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004; 232: 335-46. 10.1148/radiol.2322021326
- Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, et al. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Abdom Imaging 2015; 40: 1190-202. 10.1007/s00261-014-0277-8
- Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined Chemoradiotherapy? Dis Colon Rectum 2005; 48: 722-8. 10.1007/s10350-004-0851-1
- Capirci C, Rampin L, Erba PA, Galeotti, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neoadjuvant chemo-radiation therapy. Nucl Med Mol Imaging 2007; 34: 1583-93. 10.1007/s00259-007-0426-1
- Kristiansen C, Loft A, Berthelsen AK, Graff J, Lindebjerg J, Bisgaard C, et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum 2008; 51: 21-5. 10.1007/s10350-007-9095-1
- Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging 2012; 37: 1032-40. 10.1007/s00261-011-9839-1
- Sun W, Xu J, Hu W, Zhang Z, Shen W. The role of sequential 18(F)-FDG PET/ CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Colorectal Dis 2013; 15: e231-8. 10.1111/codi.12165
- Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys 2009; 74: 1461-9. 10.1016/j.ijrobp.2008.10.064
- Murcia MJ, Duréndez L, Frutos Esteban J, Luján MD, Frutos G, Valero JL, et al. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging; 40: 91-7. 10.1007/s00259-012-2257-y
- Rosenberg R, Herrmann K, Gertler R, Künzli B, Essler M, Lordick F, et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 2009; 24: 191-200. 10.1007/s00384-008-0616-8
- Dresen RC, Beets GL, Rutten HJT, Engelen SME, Lahaye MJ, Vliegen RFA, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009; 252: 71-80. 10.1148/radiol.2521081200
- Denecke T, Rau B, Hoffmann KT, Hildebrandt B, Ruf J, Gutberlet M, et al. Comparison of CT, and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 2005; 15: 1658-66. 10.1007/s00330-005-2658-4
- Beets-Tan RG, Beets GL, Borstlap AC, Oei TK, Teune TM, von Meyenfeldt MF, et al. Preoperative assessment of local tumour extent in advanced rectal cancer: CT or high- resolution MRI? Abdom Imaging 2000; 25: 533-41. 10.1107/s002610000086
- Wiering B, Ruers TJ, Oyen WJ. Role of FDG_PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 2004; 4: 607-13. 10.1586/14737140.4.4.607
- Park IJ, Kim HC, Yu CS, Ryu MH, Chang HM, Kim JH, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 2006; 32: 941-7. 10.1016/j.ejso.2006.05.019
- Avallone A, Aloj L, Caracò C, Delrio P, Pecori B, Tatangelo F, et al. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome. Eur J Nucl Med Mol Imaging 2012; 39: 1848-57. 10.1007/s00259-012-2229-2
- Av allone A, Aloj L, Delrio P, Pecori B, Leone A, Tatangelo F, et al. Multidisciplinary approach to rectal cancer: are we ready for selective treatment strategies? Anticancer Agents Med Chem 2013; 13: 852-60.
- Petrillo A, Fusco R, Petrillo M, Granata V, Filice S, Delrio P, et al. Dynamic contrast enhanced-MRI in locally advanced rectal cancer: value of time intensity curve visual inspection to assess neoadjuvant therapy response. J Physiol Health Photon 2014; 110: 255-67.
- Petrillo A, Fusco R, Petrillo M, Granata V, Sansone M, Avallone A, et al. Standardized index of shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol 2015; 25: 1935-45. 10.1007/s00330-014-3581-3
- Fusco R, Petrillo A, Petrillo M, Sansone M. Use of tracer kinetic models for selection of semi-quantitative features for DCE-MRI data classification. Appl Magn Reson 2013; 44: 1311-24. 10.1007/s00723-013-0481-7
- Kim SH, Lee JM, Gupta SN, Han JK, Choi BI. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Magn Reson Imaging 2014; 40: 730-7. 10.1002/jmri.24387
- Intven M, Reerink O, Philippens ME. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neoadjuvant chemoradiation. J Magn Reson Imaging 2015; 41: 1646-53. 10.1002/jmri.24718
- Lim JS, Kim D, Baek SE, Myoung S, Choi J, Shin SJ, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2012; 22: 1693-700. 10.1007/s00330-012-2416-3
- Guo JY, Reddick WE. DCE-MRI pixel-by-pixel quantitative curve pattern analysis and its application to osteosarcoma. J Magn Reson Imaging 2009; 30: 177-84. 10.1002/jmri.21785
- Lavini C, de Jonge MC, van de Sande MG, Tak PP, Nederveen AJ, Maas M. Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 2007; 25: 604-12. 10.1016/j.mri.2006.10.021
- Tuncbilek N, Karakas HM, Altaner S. Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas. Abdom Imaging 2004; 29: 166-72. 10.1007/s00261-003-0090-2
- Lambregts DM, Maas M, Stokkel M P, Beets-Tan RG. Magnetic Resonance Imaging and Other Imaging Modalities in Diagnostic and Tumor Response Evaluation. Semin Radiat Oncol 2016; 26: 193-8. 10.1016/j.semradonc.2016.02.001
- Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009; 253: 116-25. 10.1148/radiol.2532090027
- Marouf RA, Tadrosa MY, Ahmedb TY. Value of diffusion-weighted MR imaging in assessing response of neoadjuvant chemo and radiation therapy in locally advanced rectal cancer. EJRNM 2015; 46: 553-61. 10.1016/j.ejrnm.2015.03.005
- Petrillo M, Fusco R, Catalano O, Sansone M, Avallone A, Delrio P, et al. MRI for assessing response to neoadjuvant therapy in locally advanced rectal cancer using DCE-MR and DW-MR data sets: a preliminary report. Biomed Res Int 2015; 2015: 514740. 10.1155/2015/514740
- Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, et al. Diffusion-weighted MRI and MR- volumetry - in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging 2015; 33: 201-12. 10.1016/j.mri.2014.08.041
- Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, et al. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Clin Nucl Med 2013; 38: 7-12. 10.1097/RLU.0b013e3182639a58
- Martens MH, Subhani S, Heijnen LA, Lambregts DM, Buijsen J, Maas M, et al. Can perfusion MRI predict response to preoperative treatment in rectal cancer? Radiother Oncol 2015; 114: 218-23. 10.1016/j.radonc.2014.11.044
- Monguzzi L, Ippolito D, Bernasconi DP, Trattenero C, Galimberti S, Sironi S. Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol 2013; 82: 234-40. 10.1016/j.ejrad.2012.09.027
- Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009; 250: 730-9. 10.1148/radiol.2503080310
- Leccisotti L, Gambacorta MA, de Waure C, Stefanelli A, Barbaro B, Vecchio FM, et al. The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy. Eur J Nucl Med Mol Imaging 2015; 42: 657-66. 10.1007/s00259-014-2820-9
- Niccoli-Asabella A, Altini C, De Luca R, Fanelli M, Rubini D, Caliandro C, et al. Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. Biomed Res Int 2014; 2014: 952843. 10.1155/2014/952843
- Kim JW, Kim HC, Park JW, Park SC, Sohn DK, Choi HS, et al. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy. Int J Colorectal Dis 2013; 28: 1217-24. 10.1007/s00384-013-1657-1
- Palma P, Conde-Muíño R, Rodríguez-Fernández A, Segura-Jiménez I, Sánchez-Sánchez R, Martín-Cano J, et al. The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer. Radiat Oncol 2010; 5: 119. 10.1186/1748-717X-5-119
- Wieder HA, Brücher BL, Zimmermann F, Becker K, Lordick F, Beer A, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004; 22: 900-8. 10.1200/JCO.2004.07.122
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis J P, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
- Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-36. 10.7326/0003-4819-155-8-201110180-00009
- Sathyakumar K, Chandramohan A, Masih D, Jesudasan MR, Pulimood A, Eapen A. Best MRI predictors of complete response to neoadjuvant chemo-radiation in locally advanced rectal cancer. Br J Radiol 2016; 89: 20150328. 10.1259/bjr.20150328
- Jacobs L, Intven M, van Lelyveld N, Philippens M, Burbach M, Seldenrijk K, et al. Diffusion-weighted MRI for early prediction of treatment response on preoperative chemoradiotherapy for patients with locally advanced rectal cancer: a feasibility study. Ann Surg 2016; 263: 522-8. 10.1097/SLA.0000000000001311
- Chen YG, Che n MQ, Guo YY, Li SC, Wu JX, Xu BH. Apparent diffusion coefficient predicts pathology complete response of rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2016; 11: e0153944. 10.1371/journal.pone.0153944
- Choi MH, Oh SN, Rha SE, Choi JI, Lee SH, Jang HS, et al. Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging 2016; 44: 212-20. 10.1002/jmri.25117
- Kye BH, Kim HJ, Kim G, Kim JG, Cho HM. Multimodal assessments are needed for restaging after neoadjunvant chemoradiation therapy in rectal cancer patients. Cancer Res Treat 2016; 48: 561-6. 10.4143/crt.2015.114
- Ippolito D, Fior D, Trattenero C, Ponti ED, Drago S, Guerra L, et al. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer. World J Radiol 2015; 7: 509-20. 10.4329/wjr.v7.i12.509